LHDX Lucira Health, Inc.
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It has developed a testing platform that produces COVID-19 single-use test kit with molecular accuracy. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.
$19.31 -0.45 (-2.25%)
As of 02/26/2021 15:59:52 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Diagnostics & Research
USA
02/04/2021
35,867,200
660,508
$692,595,632
0.00%
SEC Edgar Online
10-Q
10-K
Common stocks
Small cap
Health Care
Diagnostics & Research
USA
02/04/2021
35,867,200
660,508
$692,595,632
0.00%
SEC Edgar Online
10-Q
10-K
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
-15.26
0.00
4.49%
0.00%
-15.26
0.00
4.49%
0.00%